Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES. (May 2023)

• Record Type: Journal Article
• Authors: Savona, M.; Mccloskey, J.; Griffiths, E.; Yee, K.; Zeidan, A.; Al-Kali, A.; Deeg, H.J.; Patel, P.; Sabloff, M.; Keating, M.-M.; Zhu, N.; Gabrail, N.; Fazal, S.; Maly, J.; Odenike, O.; Kantarjian, H.; Dezern, A.; O'Connell, C.; Roboz, G.; Busque, L.; Buckstein, R.; Amin, H.; Randhawa, J.; Leber, B.; Dao, K.-H.; Sano, Y.; Mirakhur, B.; Keer, H.; Garcia-Manero, G.
• Is Part Of: Leukemia research. Volume 128(2023)Supplement
• Publication Date: 2023-05
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2023.107271
• Languages: English
• ISSNs: 0145-2126